Disease severity in moderate-to-severe plaque psoriasis: results from the Belgian REDISCOVER study

被引：0
|
作者：
Hillary, Tom [1 ]
Ghys, Liesbeth [2 ]
Willaert, Fabienne [3 ]
Swimberghe, Sandra
Lecuyer, Myriam
Ghislain, Pierre-Dominique [4 ]
Morrens, Joachim [2 ]
Lambert, Jo [5 ]
机构：
[1] Univ Hosp Leuven, Leuven, Belgium
[2] Abbvie Belgium, Brussels, Belgium
[3] Univ Libre Bruxelles, Erasme Hosp, Dermatol, Brussels, Belgium
[4] Catholic Univ Louvain, Dermatol, Clin St Luc, Brussels, Belgium
[5] Ghent Univ Hosp, Dermatol, Ghent, Belgium
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
40351
引用
收藏
页码：AB37 / AB37
页数：1
相关论文
共 50 条
  • [41] Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium
    Carmona-Rocha, Elena
    Puig, Lluis
    IMMUNOTHERAPY, 2023, 15 (15) : 1209 - 1225
  • [42] NEW INJECTABLE DRUG TREATS MODERATE-TO-SEVERE PLAQUE PSORIASIS
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2017, 117 (06) : 23 - 23
  • [43] Apremilast in moderate-to-severe plaque psoriasis (ESTEEM 2 trial)
    Anstey, Alex
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (06) : E23 - E23
  • [44] Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population
    Papp, Kim
    Valenzuela, Fernando
    Poulin, Yves
    Bernstein, Geula
    Wasel, Norman
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2010, 14 (04) : 167 - 174
  • [45] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Egeberg, Alexander
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2101 - 2102
  • [46] Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis
    Egeberg, Alexander
    Bryld, Lars Erik
    Skov, Lone
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) : 173 - 178
  • [47] Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
    Ren, Vicky
    Dao, Harry, Jr.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2013, 6 : 75 - 80
  • [48] Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients
    Libon, Florence
    Lebas, Eve
    De Schaetzen, Virginie
    Sabatiello, Murielle
    De Schepper, Sofie
    Nikkels, Arjen F.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (09) : 947 - 955
  • [49] A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis
    Roostaeyan, Omid
    Kivelevitch, Dario
    Menter, Alan
    IMMUNOTHERAPY, 2017, 9 (12) : 963 - 978
  • [50] A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast
    Chiricozzi, Andrea
    Caposiena, Dante
    Garofalo, Virginia
    Cannizzaro, Maria Vittoria
    Chimenti, Sergio
    Saraceno, Rosita
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (03) : 237 - 249
12345